Published in World J Gastroenterol on December 21, 2013
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepat Med (2015) 0.84
Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease. Cancer Med (2016) 0.78
Genome-wide genotyping of acute myeloid leukemia with translocation t(9;11)(p22;q23) reveals novel recurrent genomic alterations. Haematologica (2014) 0.75
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30
Next-generation DNA sequencing. Nat Biotechnol (2008) 34.95
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A (2004) 33.85
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol (2008) 23.93
The cancer genome. Nature (2009) 23.13
Landscape of transcription in human cells. Nature (2012) 20.18
NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res (2005) 17.61
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (1992) 16.38
ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res (2003) 15.48
Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med (2007) 12.73
Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res (2009) 9.59
Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer (1997) 8.27
dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics (2004) 6.78
Array comparative genomic hybridization and its applications in cancer. Nat Genet (2005) 6.69
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet (2012) 6.65
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet (2012) 4.84
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38
Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med (2003) 3.93
Focus on hepatocellular carcinoma. Cancer Cell (2004) 3.49
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet (2012) 3.14
DNA copy number losses in human neoplasms. Am J Pathol (1999) 2.73
p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology (1999) 2.38
MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology (2012) 2.29
Visualizing multidimensional cancer genomics data. Genome Med (2013) 2.19
The UCSC Cancer Genomics Browser: update 2013. Nucleic Acids Res (2012) 2.18
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet (1991) 1.81
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. Hepatology (2011) 1.57
Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO). PLoS Comput Biol (2012) 1.55
Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology (2013) 1.41
Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology (1999) 1.37
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc Natl Acad Sci U S A (2008) 1.34
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma. Hepatology (2013) 1.26
Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene (1999) 1.21
PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene (1999) 1.20
OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res (2006) 1.06
Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications. World J Gastroenterol (2012) 1.05
Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11. Genes Chromosomes Cancer (2005) 1.01
Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer (2001) 1.00
Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma. Hepatology (2013) 0.97
Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinformatics (2007) 0.97
Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer (2001) 0.96
Epigenetics of hepatocellular carcinoma: role of microRNA. World J Gastroenterol (2013) 0.95
Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma. Hepatology (2010) 0.95
Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma. Oncogene (2011) 0.93
A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res (2001) 0.93
Integrated metabolome and transcriptome analysis of the NCI60 dataset. BMC Bioinformatics (2011) 0.93
Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res (1996) 0.93
Liver cancer biomarkers struggling to succeed. J Natl Cancer Inst (2007) 0.89
Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells. Lab Invest (2004) 0.87
Proteome database of hepatocellular carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.85
dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma. Hum Mutat (2011) 0.84
Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. Carcinogenesis (2013) 0.83
HCCNet: an integrated network database of hepatocellular carcinoma. Cell Res (2010) 0.83
CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines. Liver Int (2013) 0.80